bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.09.24.753565

An agentic AI environment to support biomedical research in collaborative academic environments

Abstract

Agentic artificial intelligence (AAI) is increasingly used by biomedical scientists, where it has substantially lowered the difficulty of integrating computational, statistical and data-science approaches into day-to-day research activities, assisting with project design, analysis and manuscript preparation. Significant barriers remain, however, which are unlikely to be removed solely by releasing more capable AI models. Meaningful use still demands a technical fluency that many biomedical researchers lack: a PI and their lab members must learn how to use the AAI system, establish standard operating procedures (SOPs) for managing, sharing and curating data, and enforce rules that address data privacy and security. Existing commercial AAI systems, which were designed primarily for software engineering purposes, need to be significantly re-purposed for biomedical-related data science. We present Murmurent, shared software that sits beneath the agentic AI and provides the skills, procedures and protections to address the concerns above, removing the need for a lab to develop them independently. This includes (1) infrastructure to support projects and so-called choreographies} involving multiple group members; (2) a set of specialized agents each dedicated to typical biomedical data science tasks including software and statistical development, data visualization, literature search, equity, diversity, inclusion, and decolonization (EDID) review, and others; (3) a tiered memory which can retain important research decisions, intermediate, derived outputs and sensitive data, and which can exploit this information to automatically build better contexts in AAI sessions; (4) traceability records which are used by the AAI session to better plan and execute data analyses and software builds by, for example, helping to avoid repeating decisions that lead to dead-ends; (5) enforcement of SOPs for data maintenance and data governance across all lab members; and (6) multi-user capacity to allow groups to interact and collaborate. We use the system to identify putative inhibitors of Peptidyl-prolyl cis-trans Isomerase NIMA-interacting 1 (Pin1), a protein with a shallow catalytic site making it difficult to target. We describe the construction of several approaches to identify Pin1 inhibitors and the results they yield. Murmurent is open source.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wu, T., Browne, T. S., Meawad, M., Emam, H. E., Simsam, N. H., Xia, Y., Jaafar, A., Ma, A., Kabbani, B., Gupta, V., Mucaki, E. J., Bishop, S. L., Edgell, D. R., Gloor, G., Lu, K. P., Weir, L., Zhou, X. Z., Dumeaux, V., Hallett, M. T.. 2026-09-29. An agentic AI environment to support biomedical research in collaborative academic environments. https://doi.org/10.64898/2026.09.24.753565

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Transcript quantification using context-aware MAPQ modeling

Long-read RNA-sequencing enables accurate transcript-level quantification, but prior static filtering of MAPping Quality (MAPQ) can ignore transcriptome-intrinsic ambiguity, and discarding reads on this basis distorts abundance estimates. We present CALMeR (Context-Aware Long-read MAPQ-based Rescuer), which conditions MAPQ filtering on transcript properties rather than a fixed cutoff. CALMeR fits a zero-one inflated beta regression on various transcript and read-level features to model the expected MAPQ distribution for each alignment. Reads whose MAPQ fits this context, such as low-MAPQ reads from multi-isoform genes and paralog families are retained; reads with anomalously low MAPQ are removed as likely artifacts. Retained reads can be summed per transcript or passed to any downstream quantifier. Compared with a MAPQ [≥] 1 filter and expectation-maximization-based transcript quantification methods, CALMeR recovers more spike-in transcripts and better matches known spike-in concentrations. CALMeR is available at https://github.com/sparthib/CALMeR.

bioinformatics↗

Structure-resolved fold annotation of the medicinal-leech salivary-EV cargo: a Ly-6/uPAR three-finger scaffold and a structurally dark fraction

Many proteins that medicinal leeches package into salivary extracellular vesicles (EVs) carry no interpretable sequence annotation, so the least-characterised part of a pharmacologically important secretome lacks even a fold assignment. A companion Astral-DIA study of Hirudinaria manillensis nominated 17 ultra-enriched candidate EV cargo proteins. Here we ask whether structure prediction and structural search can assign folds where sequence methods fail, and which candidates remain unresolved under prespecified criteria. With an offline pipeline (ESMFold, TM-align, Foldseek against AFDB-SwissProt and PDB100, UniRef90 search, protein-to-genome alignment), the candidates separate into intracellular/membrane machinery and a secreted, cysteine-dense fraction of three proteins with no Pfam domain. The predicted structure of the leech Protein-sleepless homolog g21166 supports its assignment to the Ly-6/uPAR three-finger fold (TM 0.58 vs CD59; best significant PDB match Lynx1); no function is inferred. g436 and g20791 returned no match meeting the criterion (alnTM [≥] 0.5, E [≤] 0.05) in either database, g436 even after homolog-informed modelling. Gene structure and splice junctions support a conserved locus for the two-Trypsin-segment model g8114 (catalytic unit not established). A Boltz-2 thrombin pilot did not support target engagement, and a pre-registered nicotinic test was terminated as undecidable. The results yield a structure-informed shortlist for experimental follow-up.

bioinformatics↗

EpiRank: partner-agnostic surface-patch retrieval for epitope prediction of protein binding interfaces

Structure-based interface predictors are normally reported as a single pooled ROC AUC over a residue test set. For a protein designer the operative question is different and much harder: given one target chain, will the top-ranked surface patch be a real binding site? We built EpiRank, a partner-agnostic epitope predictor, on HumanPPI 29,246 predicted human dimers, 12,296 target chains, 4.18 M residues using only single-chain geometry and physicochemistry (170 features, no partner, no sequence search, no structural alphabet), and evaluated it as a retrieval problem with homology- and partner-graph-controlled splits, on the 3,529 chains that survive an explicit partner-contamination filter. The model places a real epitope in its top-ranked patch 64 % of the time. That number is far less informative than it looks. Compact patches placed at random hit a real epitope 41 % of the time under the same rule, so the model's lift is 1.57 x, not 64 %; 54 % of all predicted patches land on nothing; and when the same chains are scored by models trained on a 2,000-chain and an 11,669-chain superset, a substantial fraction change answer while the aggregate barely moves. We document four specific ways this task invites overstatement partner-graph percolation across splits, single-linkage homology percolation at the conventional 30 % identity threshold, a count-only hit rule that rewards spatial smoothing rather than signal, and hotspot precision conditioned on success, which ranks a random baseline above the trained model. Each was hit during development and each inverted a conclusion we had already drawn. We argue that interface-prediction papers should report lift over a geometry-matched random baseline, patch precision, and per-target stability alongside AUC, and we release the evaluation harness that computes them.

bioinformatics↗